Congenital Hyperinsulinism Treatment Market

Starting at US$ 5000

Buy Now

Key Players

  • AmideBio LLC
  • Crinetics Pharmaceuticals
  • De Motu Cordis
  • Eiger Biopharmaceuticals
  • Eli Lilly and Company
  • Hanmi Pharmaceutical
  • Millendo Therapeutics
  • Novartis
  • Novo Nordisk A/S
  • Recordati Rare Diseases Inc
  • Rezolute
  • Rhythm Pharmaceuticals
  • Soleno Therapeutics
  • Ultragenyx Pharmaceutical Inc
  • Xeris Pharmaceuticals
  • Zealand Pharma A/S
Future Market Insights

Congenital Hyperinsulinism Treatment Market